Albireo Pharma (ALBO) Earnings
|
Expand Research on ALBO
| Next EPS Date | N/A | EPS Growth Rate | N/A |
|---|---|---|---|
| Average EPS % Beat Rate | -8.0% | Revenue Growth Rate | N/A |
| Average % Move 1-Wk after EPS | -7.2% | Normal Earnings Time | Before Open |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 3/15/23 | Q422 | N/A | -$1.99 | N/A | N/A | $9.88M | N/A | N/A | N/A | ||
| 11/15/22 | Q322 | N/A | -$2.08 | N/A | N/A | $8.47M | N/A | N/A | N/A | ||
| 8/15/22 | Q222 | -$1.90 | -$1.83 | -$0.07 | $2.43M | $9.52M | N/A |  | | Details | |
| 8/8/19 |  |
Q219 | -$1.35 | -$1.43 | +$0.08 | $1.25M | $770K | N/A | | | Details |
| 5/9/19 | |
Q119 | -$1.39 | -$1.32 | -$0.07 | $570K | $970K | N/A | | | Details |
3/7/19  |
|
Q418 | N/A | -$1.16 | N/A | N/A | $1.15M | N/A | N/A | N/A | |
| 11/13/18 | |
Q318 | -$1.17 | N/A | N/A | $237K | $1.27M | N/A | | | Details |
| 8/7/18 | |
Q218 | -$1.22 | -$0.95 | -$0.27 | N/A | $570K | N/A | | | Details |
